Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

Source:http://linkedlifedata.com/resource/pubmed/id/19204207

J. Clin. Oncol. 2009 Mar 10 27 8 1268-74

Download in:

View as

General Info

PMID
19204207